Ricoh announces strategic business partnership with Elixirgen Scientific
TOKYO, Japan, 20 June 2019 – Ricoh Company, Ltd., (Tokyo, Japan) has announced it has entered into a strategic business partnership with Elixirgen Scientific, Inc., (Baltimore, Maryland, USA), to develop innovative biomedical products and services that support drug discovery based on cell differentiation1 technology.
1 Differentiation: The process in which a cell becomes specialized in order to perform a specific function, as in case of a liver cell, a blood cell or a neuron.
2 Induced pluripotent stem (iPS) cell: Cell with pluripotency that can introduce several kinds of genes into somatic cells and can differentiate into many cells like ES cells, and has self-replication ability that can be maintained even after division and proliferation.
3 Cell-chip: Living cells in a well, which is used for drug safety and efficacy testing before any testing on humans or animals.
4 Quick-Tissue™ Technology: A revolutionary new technology to generate human cells, tissues, and organs using potent cocktails of transcription factors. These cocktails transform cells into high-quality tissues in a scalable, speedy manner. Excellent transcription are using two different ways: synthetic mRNAs or Sendai virus vectors.
5 Embryonic stem cell: Pluripotent cell that is produced by obtaining and culturing a part of blastocyst stage embryos with slightly advanced development from fertilized eggs of animals.
6 Mature cell: Cell that has completed natural growth or development.
About Elixirgen
Elixirgen is a biotech company specializing in stem cell technology located at the Science + Technology Park at Johns Hopkins in Baltimore, Maryland, USA. In the stem cell industry, the length of time of differentiation from iPS/ES cells to specific cells together with low efficiency are factors that effect cost. Elixirgen Scientific has succeeded in commercializing technology that can shorten the speed of differentiation induction to approximately one week. For further information, please visit www.elixirgen.com.
|Om Ricoh|
Ricoh styrker digitale arbeidsplasser ved å bruke innovative teknologier og tjenester som gjør det mulig for enkeltpersoner å jobbe smartere fra hvor som helst.
Med kunnskap og organisatoriske evner opparbeidet gjennom sin 85-årige historie, er Ricoh en ledende leverandør av digitale tjenester, informasjonsadministrasjon og utskriftsløsninger designet for å støtte digital transformasjon og optimalisere forretningsytelsen.
Ricoh Group har hovedkontor i Tokyo og har store virksomheter over hele verden, og produktene og tjenestene deres når nå kunder i omtrent 200 land og regioner. I regnskapsåret som ble avsluttet mars 2022, hadde Ricoh Group et verdensomspennende salg på 1758 milliarder yen (ca. 14,5 milliarder USD).
For mer informasjon, vennligst besøk www.ricoh-europe.com
empty© 2022 RICOH COMPANY, LTD. Alle rettigheter forbeholdt. Alle refererte produktnavn er varemerker for deres respektive selskaper.
Mediekontakt:
Ricoh Europe PLC
Jack Gibson
E-post: media@ricoh-europe.com
Hjemmeside: www.ricoh-europe.com